相似文献
1
Evaluation of the E test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long-term bladder catheterization.
J Clin Microbiol. 1998 Mar;36(3):824-6. doi: 10.1128/JCM.36.3.824-826.1998.
2
Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients.
J Clin Microbiol. 1995 Dec;33(12):3191-3. doi: 10.1128/jcm.33.12.3191-3193.1995.
3
Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa.
J Clin Microbiol. 1992 Oct;30(10):2709-13. doi: 10.1128/jcm.30.10.2709-2713.1992.
4
Evaluation of the E test in testing susceptibility of Pseudomonas aeruginosa to tobramycin.
Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):177-80. doi: 10.1007/BF01967074.
5
Comparison of E-test with agar dilution methods in testing susceptibility of N. gonorrhoeae to azithromycin.
Sex Transm Dis. 1997 May;24(5):257-60. doi: 10.1097/00007435-199705000-00004.
6
A comparison of serial plate agar dilution, Bauer-Kirby disk diffusion, and the Vitek AutoMicrobic system for the determination of susceptibilities of Klebsiella spp., Enterobacter spp., and Pseudomonas aeruginosa to ten antimicrobial agents.
Diagn Microbiol Infect Dis. 1994 Apr;18(4):251-8. doi: 10.1016/0732-8893(94)90028-0.
7
Comparison of the Micronaut Merlin automated broth microtiter system with the standard agar dilution method for antimicrobial susceptibility testing of mucoid and nonmucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Eur J Clin Microbiol Infect Dis. 2004 Oct;23(10):765-71. doi: 10.1007/s10096-004-1212-7.
8
Comparison of the Sceptor Pseudomonas Plus MIC Panel with agar dilution for susceptibility testing of Pseudomonas aeruginosa.
J Clin Microbiol. 1992 Oct;30(10):2714-6. doi: 10.1128/jcm.30.10.2714-2716.1992.
9
[Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
Mikrobiyol Bul. 2011 Jul;45(3):411-21.
10
[Comparative evaluation of 2 methods--dilution in agar and diffusion in agar--in determining Pseudomonas aeruginosa sensitivity to antibiotics].
Antibiot Med Biotekhnol. 1985 Jul;30(7):511-6.
引用本文的文献
1
Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods.
Front Microbiol. 2025 Feb 25;16:1549044. doi: 10.3389/fmicb.2025.1549044. eCollection 2025.
2
Occurrence, antimicrobial susceptibility, and pathogenic factors of in canine clinical samples.
Vet World. 2021 Apr;14(4):978-985. doi: 10.14202/vetworld.2021.978-985. Epub 2021 Apr 23.
3
Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts.
Sci Rep. 2018 Aug 21;8(1):12512. doi: 10.1038/s41598-018-30972-y.
4
Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution.
J Clin Microbiol. 2007 Jul;45(7):2162-5. doi: 10.1128/JCM.00063-07. Epub 2007 May 2.
5
Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):25-30. doi: 10.1007/s10096-005-0076-9.
6
Evaluation of a novel automated chemiluminescent assay system for antimicrobial susceptibility testing.
J Clin Microbiol. 2003 Jan;41(1):279-84. doi: 10.1128/JCM.41.1.279-284.2003.
本文引用的文献
1
Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.
J Clin Microbiol. 1997 Jul;35(7):1842-6. doi: 10.1128/jcm.35.7.1842-1846.1997.
2
Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients.
J Clin Microbiol. 1995 Dec;33(12):3191-3. doi: 10.1128/jcm.33.12.3191-3193.1995.
3
Epidemiology of quinolone resistance. Eastern hemisphere.
Drugs. 1995;49 Suppl 2:43-7. doi: 10.2165/00003495-199500492-00008.
4
Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies.
Pharmacotherapy. 1995 May-Jun;15(3):279-91.
5
Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study.
J Clin Microbiol. 1980 Sep;12(3):375-90. doi: 10.1128/jcm.12.3.375-390.1980.
6
Reduction of mortality associated with nosocomial urinary tract infection.
Lancet. 1983 Apr 23;1(8330):893-7. doi: 10.1016/s0140-6736(83)91327-2.
7
Microbial resistance to antibiotics. An evolving and persistent problem.
Lancet. 1982 Jul 10;2(8289):83-8. doi: 10.1016/s0140-6736(82)91701-9.
8
The nationwide nosocomial infection rate. A new need for vital statistics.
Am J Epidemiol. 1985 Feb;121(2):159-67. doi: 10.1093/oxfordjournals.aje.a113988.
9
Evaluation of the E test, a novel method of quantifying antimicrobial activity.
J Antimicrob Chemother. 1991 Feb;27(2):185-90. doi: 10.1093/jac/27.2.185.
10
Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.
J Clin Microbiol. 1991 Mar;29(3):533-8. doi: 10.1128/jcm.29.3.533-538.1991.
Zotero 插件